Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect

Erez N Baruch1,2, Jingjing Wang3, Jennifer A Wargo2,4

  • 1Department of Internal Medicine, The University of Texas Health Science Center, Houston, Texas. jwargo@mdanderson.org ENBaruch@mdanderson.org.

Insights

The gut microbiota influences cancer immunotherapy effectiveness by modulating immune cell activity. Strategies like fecal transplants and probiotics aim to enhance anti-cancer immune responses.

Area of Science:

  • Immunology
  • Microbiology
  • Oncology

Background:

  • Preclinical studies link gut microbiota composition to cancer immunotherapy efficacy.
  • Clinical trials are exploring microbiota modulation to improve treatment outcomes.
  • Mechanisms underlying microbiota's influence on immunotherapy remain incompletely understood.

Purpose of the Study:

  • To review the mechanisms by which gut microbiota impacts immunotherapy effectiveness.
  • To discuss various gut microbiota modulation strategies and their therapeutic potential.
  • To explore the immune activation pathways involved.

Main Methods:

  • Review of preclinical and clinical findings on gut microbiota modulation.
  • Analysis of studies involving fecal transplantation, probiotics, consortia, and diet.
  • Discussion of proposed immune activation mechanisms.

Main Results:

  • Favorable gut microbiota modulation correlates with increased CD8+ T cell infiltration into tumors.
  • Enhanced microbiota is associated with increased T-helper type 1 cell and dendritic cell activity.
  • Microbiota modulation can lead to a reduction in immunosuppressive cells within the tumor microenvironment.

Conclusions:

  • Gut microbiota influences immunotherapy by activating pattern recognition receptors, molecular mimicry, and metabolite production.
  • Various modulation techniques show therapeutic potential but have limitations.
  • Understanding these mechanisms is crucial for optimizing cancer immunotherapy.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
801
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
599
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
5.5K